ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1275

Unexpected Changes in Physical and Psychological Measures Among Georgia Lupus Patients During the Early Weeks of the COVID-19 Pandemic in the United States, March 30–April 21, 2020

S. Sam Lim1, Kristina Theis2, Charmayne Dunlop-Thomas1, Gaobin Bao1, Charles Helmick2, Caroline Gordon3 and Cristina Drenkard4, 1Emory University, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3University of Birmingham, Birmingham, England, United Kingdom, 4Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

Meeting: ACR Convergence 2020

Keywords: COVID-19, Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: An infectious disease outbreak can lead to negative physical and psychological consequences in the general public, as shown by the early COVID-19 pandemic, through significant negative global impacts on depression, anxiety, and stress.  These outcomes are also known to be common among people with lupus.  To evaluate the early impacts of the COVID-19 pandemic, we examined changes in standardized patient-reported outcomes in a cohort of patients with SLE between 2018–2019 and early 2020 and evaluated how the pandemic’s impact on physical and psychological health differed by subgroups, particularly among black persons, who are at higher risk for adverse outcomes from both SLE and COVID-19.

Methods: Georgians Organized Against Lupus (GOAL) is a Centers for Disease Control and Prevention-supported population-based validated cohort of patients with SLE in Atlanta who complete patient-matched annual surveys across multiple domains. We analyzed sociodemographics and validated measures of lupus characteristics and physical and psychological parameters (see table footnotes) from surveys before (2018–2019) and during the pandemic’s early onset (March 30–April 21, 2020). The 2020 surveys closely corresponded to the statewide shelter-in-place order in Georgia (April 3–24). We conducted descriptive analyses of prevalence (%) estimates with standard deviations (SD) and temporal changes in scale scores and paired t-tests for statistically significant differences (ɑ=0.05); analyses were examined overall and stratified by sex and race.

Results: Overall, 316 participants had survey data from both time points. Most were black (76.6%) and female (93.4%); more than a quarter live in poverty (28.5%) (Table 1). Compared with before the pandemic, no physical or psychosocial measure worsened during the early onset of the pandemic. Rather, there were small, statistically significant improvements in stress, pain interference, fatigue, depression, anger, everyday discrimination, and emotional support overall, particularly in females and black persons (Table 2). Only Pain Interference improved significantly in males and Discrimination in white respondents (Table 2). No changes were observed in disease activity, disease damage, insurance, or poverty status.

Conclusion: We expected to see worsening in most measures among patients with SLE early in the COVID-19 pandemic, so the absence of deterioration and even minor improvements is notable and may be explained by several hypotheses.  These findings may reflect baseline severity of many outcomes for people with SLE.  The study period was early in the pandemic, so potential negative financial pressures may not have been fully realized and may have been mitigated by economic impact payments from acute policy measures.  Many negative consequences of living with SLE (isolation, reduced activity, anxiety, and fear of stigma) became a reality for the general population. This may have made those with SLE feel closer to the norm while limiting opportunities for certain negative experiences, including discrimination. Importantly, longer-term impacts of the pandemic may reverse these findings and ultimately lead to more severe negative outcomes, requiring continued close study.


Disclosure: S. Lim, None; K. Theis, None; C. Dunlop-Thomas, None; G. Bao, None; C. Helmick, None; C. Gordon, UCB, 1, 2, 3, 4, CDC, 1, MGP, 1; C. Drenkard, None.

To cite this abstract in AMA style:

Lim S, Theis K, Dunlop-Thomas C, Bao G, Helmick C, Gordon C, Drenkard C. Unexpected Changes in Physical and Psychological Measures Among Georgia Lupus Patients During the Early Weeks of the COVID-19 Pandemic in the United States, March 30–April 21, 2020 [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/unexpected-changes-in-physical-and-psychological-measures-among-georgia-lupus-patients-during-the-early-weeks-of-the-covid-19-pandemic-in-the-united-states-march-30-april-21-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unexpected-changes-in-physical-and-psychological-measures-among-georgia-lupus-patients-during-the-early-weeks-of-the-covid-19-pandemic-in-the-united-states-march-30-april-21-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology